©Naobios
Duhn Therapeutics, launched by Landmark BioVentures, signs global license agreement with OM Pharma to further advance clinical-stage, lipid-based cancer immunotherapy
©Courtesy of OM Pharma
Naobios and European Vaccine Initiative partner up to manufacture Respiratory Syncytial Virus (RSV) challenge agent
©Naobios
Exeliom Biosciences collaborates with REMIND in MAINTAIN POP study
Pr. Matthieu Allez & Pr. Harry Sokol
Banook Group deploys growth strategy with acquisitions of Keosys and B.Research
© Banook Group
Bio-Sourcing and Afrigen Biologics partner on groundbreaking biomanufacturing platform to improve access to biotherapeutics in South Africa
Bio-Sourcing – Afrigen
Bio-Sourcing, Ciloa and Intract Pharma launch €3.4M EU project in inflammatory indications with €1.9M subsidies from EUREKA Eurostars
©iStock
BioWin and MEDVIA sign first strategic collaboration between health clusters in Wallonia and Flanders
Naobios and Sumagen sign exclusive partnership to develop HIV vaccine
©Naobios
Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma
©Carthera